home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
07/24/2024
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing
read more
06/26/2024
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
read more
05/31/2024
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
read more
05/15/2024
PainReform Provides Business Update for the First Quarter of 2024
read more
05/08/2024
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
read more
04/18/2024
PainReform Announces Closing of $4 Million Public Offering
read more